Cardiovascular Disease Stocks List

Cardiovascular Disease Stocks Recent News

Date Stock Title
May 28 JNJ Sector Update: Health Care Stocks Fall Late Afternoon
May 28 JNJ Sector Update: Health Care Stocks Retreat Tuesday Afternoon
May 28 JNJ Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion
May 28 JNJ Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally
May 28 NNOX Nano-X Imaging Ltd. (NNOX) Q1 2024 Earnings Call Transcript
May 28 APLT Applied Therapeutics: Navigating Challenges In ARI Development For Rare Diseases
May 28 AMRN Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.
May 28 NNOX Nano-X Imaging Non-GAAP EPS of $0.14, revenue of $2.56M misses by $1.86M
May 28 JNJ J&J to buy eczema drug developer Yellow Jersey for over $1B
May 28 NNOX Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update
May 28 JNJ Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
May 28 JNJ Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
May 28 JNJ J&J gains another bispecific antibody with $1.25B skin drug buy
May 28 JNJ J&J’s Nisha Johnson on Ethizia wound-sealing patch, biosurgery market
May 28 NNOX Ledger starts shipping its high-end hardware crypto wallet
May 27 JNJ 3 Top Dividend Stocks to Maximize Your Retirement Income
May 27 JNJ 5 Magnificent Stocks Being Bought for Warren Buffett's $646 Million "Secret" Portfolio
May 24 JNJ Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know
May 24 NNOX Nano-X Imaging Q1 Earnings Preview
May 24 FLGT Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags